ID   CHO/hPDPN
AC   CVCL_D2U5
SY   CHO-K1/hPDPN; CHO/hPDPN-FLAG
RX   Patent=US10227407;
RX   PubMed=25080943;
RX   PubMed=26492619;
RX   PubMed=26683179;
RX   PubMed=26788987;
RX   PubMed=26937552;
RX   PubMed=27267652;
RX   PubMed=27328060;
RX   PubMed=27380308;
CC   Transfected with: HGNC; 29602; PDPN (with a C-terminal FLAG tag).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 30-01-24; Version: 1
//
RX   Patent=US10227407;
RA   Kato Y., Kaneko M.K.;
RT   "Anti-podoplanin antibody.";
RL   Patent number US10227407, 12-Mar-2019.
//
RX   PubMed=25080943; DOI=10.1038/srep05924;
RA   Kato Y., Kaneko M.K.;
RT   "A cancer-specific monoclonal antibody recognizes the aberrantly
RT   glycosylated podoplanin.";
RL   Sci. Rep. 4:5924-5924(2014).
//
RX   PubMed=26492619; DOI=10.1089/mab.2015.0018;
RA   Ogasawara S., Oki H., Kaneko M.K., Hozumi Y., Liu X., Honma R.,
RA   Fujii Y., Nakamura T., Goto K., Takagi M., Kato Y.;
RT   "Development of monoclonal antibody LpMab-10 recognizing
RT   non-glycosylated PLAG1/2 domain including Thr34 of human
RT   podoplanin.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 34:318-326(2015).
//
RX   PubMed=26683179; DOI=10.1089/mab.2015.0041;
RA   Oki H., Honma R., Ogasawara S., Fujii Y., Liu X., Takagi M.,
RA   Kaneko M.K., Kato Y.;
RT   "Development of sensitive monoclonal antibody PMab-2 against rat
RT   podoplanin.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 34:396-403(2015).
//
RX   PubMed=26788987; DOI=10.1089/mab.2015.0066;
RA   Honma R., Fujii Y., Ogasawara S., Oki H., Liu X., Nakamura T.,
RA   Kaneko M.K., Takagi M., Kato Y.;
RT   "Establishment of novel monoclonal antibody PMab-32 against rabbit
RT   podoplanin.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 35:41-47(2016).
//
RX   PubMed=26937552; DOI=10.1089/mab.2015.0077;
RA   Kato Y., Ogasawara S., Oki H., Honma R., Takagi M., Fujii Y.,
RA   Nakamura T., Saidoh N., Kanno H., Umetsu M., Kamata S., Kubo H.,
RA   Yamada M., Sawa Y., Morita K.-i., Harada H., Suzuki H., Kaneko M.K.;
RT   "Novel monoclonal antibody LpMab-17 developed by CasMab technology
RT   distinguishes human podoplanin from monkey podoplanin.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 35:109-116(2016).
//
RX   PubMed=27267652; DOI=10.1089/mab.2016.0016;
RA   Honma R., Ogasawara S., Kaneko M.K., Fujii Y., Oki H., Nakamura T.,
RA   Takagi M., Konnai S., Kato Y.;
RT   "PMab-44 detects bovine podoplanin in immunohistochemistry.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 35:186-190(2016).
//
RX   PubMed=27328060; DOI=10.1089/mab.2016.0006;
RA   Ogasawara S., Kaneko M.K., Honma R., Oki H., Fujii Y., Takagi M.,
RA   Suzuki H., Kato Y.;
RT   "Establishment of mouse monoclonal antibody LpMab-13 against human
RT   podoplanin.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 35:155-162(2016).
//
RX   PubMed=27380308; DOI=10.1089/mab.2016.0022;
RA   Honma R., Kaneko M.K., Ogasawara S., Fujii Y., Konnai S., Takagi M.,
RA   Kato Y.;
RT   "Specific detection of dog podoplanin expressed in renal glomerulus by
RT   a novel monoclonal antibody PMab-38 in immunohistochemistry.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 35:212-216(2016).
//